Background illustration for clinical trials search

Paid Clinical Trials Saint Paul

Discover 1,024 paid clinical trials in Saint Paul, Minnesota. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)

for
Primary Membranous Nephropathy
Location: Edina MN, Wauwatosa WI, Hinsdale IL, Indianapolis IN,
Sponsor: Vertex Pharmaceuticals Incorporated

Sex: All

Age: 18 - 70+

Code: NCT07204275

Phase 2, Phase 3, Recruiting

A Study to Assess the Effects of Zigakibart on IgA Nephropathy.

for
Immunoglobulin A Nephropathy (IgAN)
Location: Edina MN, Iowa City IA, Denver CO, Acworth GA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07146906

Phase 2, Recruiting

Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab

for
Relapsing Multiple Sclerosis
Location: Golden Valley MN, Plymouth MN, Iowa City IA,
Sponsor: TG Therapeutics, Inc.

Sex: All

Age: 18 - 65

Code: NCT05877963

Phase 3, Recruiting

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

for
Relapsing Multiple Sclerosis, Multiple Sclerosis
Location: Golden Valley MN, Plymouth MN, Neenah WI, Waukesha WI,
Sponsor: TG Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06433752

Recruiting

Telescope Exchange Study

for
Age-related Macular Degeneration
Location: Stillwater MN, Minnetonka MN, Ann Arbor MI,
Sponsor: VisionCare, Inc.

Sex: All

Age: 65+

Code: NCT03011554

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration

for
Neovascular Age-related Macular Degeneration, nAMD
Location: Edina MN, Elmhurst IL, Chicago IL, St Louis MO,
Sponsor: Amgen

Sex: All

Age: 50+

Code: NCT07614776

Phase 3, Recruiting

Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)

for
Neovascular Age-related Macular Degeneration
Location: Edina MN, Rochester MN, West Des Moines IA, Oak Lawn IL,
Sponsor: AbbVie

Sex: All

Age: 50+

Code: NCT07007065

Phase 3, Recruiting

Post-Market Clinical Study of Functional Motion Outcomes in Subjects Treated With the Minuteman Device

for
Degenerative Conditions of the Lumbar Spine,
Location: Edina MN, Indianapolis IN, Charleston WV, Newnan GA,
Sponsor: Spinal Simplicity LLC

Sex: All

Age: 18+

Code: NCT06355791

Recruiting

Lumbar & Sacroiliac Fusion Study Involving Previously Implanted Devices

for
Fusion of Spine, Sacroiliac; Fusion
Location: Edina MN, Kansas City KS, Charleston WV, Ardmore OK
Sponsor: Spinal Simplicity LLC

Sex: All

Age: 18+

Code: NCT07204288

Recruiting

Visual and Patient Reported Outcomes With Clareon TruPlus

for
Cataract
Location: Saint Louis Park MN
Sponsor: OVO LASIK + Lens

Sex: All

Age: 18+

Code: NCT07648355

Recruiting

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

for
Geographic Atrophy, Macular Degeneration
Location: Saint Louis Park MN, Lemont IL, Grand Rapids MI,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 60+

Code: NCT06635148

Phase 2, Phase 3, Recruiting

Retinal Detachment Prevention (Laser Prophylaxis) in Stickler Syndrome (SS)

for
Stickler Syndrome Type 1, Stickler Syndrome Type 2
Location: Minneapolis MN, Rochester MN, Royal Oak MI,
Sponsor: Helen Keller Eye Research Foundation

Sex: All

Age: 0+

Code: NCT07146516

Recruiting

Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR

for
Proliferative Diabetic Retinopathy (PDR)
Location: Saint Louis Park MN, Rochester MN, West Des Moines IA,
Sponsor: Jaeb Center for Health Research

Sex: All

Age: 18+

Code: NCT06790784

Phase 3, Recruiting

A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK

for
Macular Edema Secondary to Inflammation
Location: Saint Louis Park MN, Wausau WI, Sioux Falls SD,
Sponsor: Kodiak Sciences Inc

Sex: All

Age: 18+

Code: NCT06990399

Phase 3, Recruiting

A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE

for
Macular Edema Secondary to Inflammation
Location: Saint Louis Park MN, Wausau WI, Sioux Falls SD,
Sponsor: Kodiak Sciences Inc

Sex: All

Age: 18+

Code: NCT06996080

Phase 3, Recruiting

Technical Description of Cooled Radiofrequency Ablation of Lumbar Medial Branches for the Treatment of Lumbar Facet Pain

for
Lumbar Facet Joint Pain
Location: Edina MN
Sponsor: Mehul Desai

Sex: All

Age: 18 - 70+

Code: NCT01590004

Recruiting

A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma

for
Primary Open Angle Glaucoma
Location: Minneapolis MN, Kenosha WI, Omaha NE, Fraser MI,
Sponsor: AbbVie

Sex: All

Age: 45+

Code: NCT06822738

Phase 3, Recruiting

A Multicenter, Randomized, Vehicle-Controlled, Double-Masked to Open-Label Study to Evaluate the Safety and Efficacy of Lacripep in Subjects With Neurotrophic Keratitis

for
Neurotrophic Keratitis
Location: Minneapolis MN, Carmel IN, New York NY,
Sponsor: TearSolutions, Inc.

Sex: All

Age: 18+

Code: NCT07568730

Phase 2, Recruiting

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

for
Triple-Negative Breast Cancer
Location: Saint Louis Park MN, Sioux Falls SD, Fargo ND,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06393374

Phase 3, Recruiting

A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)

for
Renal Cell Carcinoma
Location: Saint Louis Park MN, Omaha NE, Nashville TN,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07227402

Phase 3, Recruiting